CN Patent

CN101827595B — 作为神经肽y2受体调节剂的取代的哌嗪和哌啶类

Assigned to Novartis AG · Expires 2013-07-24 · 13y expired

What this patent protects

本发明涉及游离碱形式或酸加成盐形式的式(I)化合物：其中取代基如说明书中所定义；涉及其制备、其作为药物的用途和包含它的药物。

USPTO Abstract

本发明涉及游离碱形式或酸加成盐形式的式(I)化合物：其中取代基如说明书中所定义；涉及其制备、其作为药物的用途和包含它的药物。

Drugs covered by this patent

tepotinib-hydrochloride (TEPOTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN101827595B
Jurisdiction: CN
Classification: —
Expires: 2013-07-24
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.